iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced approval by the U.S. Food and Drug Administration (FDA) for use of the company's next generation mammography computer-aided detection (CAD) platform, PowerLook Advanced Mammography Platform (AMP)TM, with Digital CAD for Philips' MicroDose Full-Field Digital Mammography System.
“This further broadens our partnerships with leading digital mammography companies and provides radiologists with an innovative combination of assessment tools to improve patient care.”
"We are pleased to provide our customers with a comprehensive mammography solution. This partnership brings together our unique spectral imaging capability enabled through photon counting technology that lets us deliver the best IQ with the lowest dose in the industry and iCAD's industry-leading CAD solution to deliver workflow efficiencies and enhanced patient care," said Kevin Tahmoush, Business Leader for Mammography Solutions of Philips. "Additionally, the modular design of iCAD's PowerLook AMP and the industry-leading CAD product provides our MicroDose customers with unmatched flexibility to choose the products and functionality they need to work more efficiently."
"With this recent FDA approval, we will now be able to offer PowerLook AMP, our next generation digital mammography CAD platform, with the Philips MicroDose Full-Field Digital Mammography System," said Ken Ferry, CEO of iCAD. "This further broadens our partnerships with leading digital mammography companies and provides radiologists with an innovative combination of assessment tools to improve patient care."
PowerLook AMP provides radiologists with the ability to customize their CAD solution to meet the needs of their individual work environment. The technology expands on iCAD's SecondLook Digital algorithm and is the CAD platform upon which all future breast imaging CAD offerings from iCAD will be built. PowerLook AMP's CAD metrics offer industry-leading tissue and lesion characteristics to support the breast imager's workflow.
iCAD's PowerLook AMP's flexible DICOM connectivity solution supports direct integration with Philips' IntelliSpace Breast workstation as well as enabling universal compatibility with leading PACS and Review Workstations. Additional modules are expected to be developed and integrated into PowerLook AMP in the future.
New vaccine shows potential in preventing recurrence of triple-negative breast cancer